A5079484314- Heart Failure Treatment and Management
- Coronary Interventions and Diagnostics
- Cardiovascular Function and Risk Factors
- Aortic aneurysm repair treatments
- Atrial Fibrillation Management and Outcomes
- Cardiac pacing and defibrillation studies
- Cardiac Structural Anomalies and Repair
- Viral Infections and Immunology Research
- Cardiac Valve Diseases and Treatments
- Peripheral Artery Disease Management
- Antiplatelet Therapy and Cardiovascular Diseases
- Advanced Optical Sensing Technologies
- Pericarditis and Cardiac Tamponade
- Acute Myocardial Infarction Research
- Lipoproteins and Cardiovascular Health
- Leptospirosis research and findings
- Venous Thromboembolism Diagnosis and Management
- ECG Monitoring and Analysis
- Vascular anomalies and interventions
- Cardiac, Anesthesia and Surgical Outcomes
- Adrenal Hormones and Disorders
- Central Venous Catheters and Hemodialysis
- COVID-19 and healthcare impacts
- Peripheral Neuropathies and Disorders
- Chronic Disease Management Strategies
Hospital Sultanah Bahiyah
2015-2024
Ministry of Health
2023
Abstract Aims Heart failure (HF) is a growing health problem, yet there are limited data on patients with HF in Malaysia. The Malaysian Failure (MY‐HF) Registry aims to gain insights into the epidemiology, aetiology, management, and outcome of identify areas for improvement within national services. Methods results MY‐HF 3‐year prospective, observational study comprising 2717 admitted acute HF. We report description baseline at admission outcomes index hospitalization these patients. mean...
Our case illustrated zero-fluoroscopic approach on AVNRT ablation in a pregnant lady. A 40 years old gravida 9 para 8 lady with underlying hypertension and recurrent supraventricular tachycardia (SVT) was referred to Cardiology clinic for further management. She had multiple admissions district hospital throughout year subsequently our center. is currently at 28 weeks presented frequent palpitation episodes within day, European Heart Rhythm Association III,1 managed labetalol by an...
Totally implantable venous access devices (TIVADs) are routinely used in oncology patients, especially those requiring long-term chemotherapy. However, they associated with minimal complications including catheter fracture. The fundamental approach for dislodged TIVAD is via percutaneous method. Reported here a case of 62-year-old woman underlying rectosigmoid carcinoma presenting port within the right atrial appendage and distal end lodged deeply into hepatic vein. After multiple...
Abstract Funding Acknowledgements Type of funding sources: Private company. Main source(s): Novartis Corporation Sdn Bhd Background Heart failure is a debilitating disease associated with multiple comorbidities and poor prognosis. Dyslipidemia, the top 5 most common comorbidities, including HF patients. Nonetheless, lipid profiles in population scarcely available poorly understood. Purpose This report aimed to describe in-hospital outcome hospitalized Methods MYHF registry prospective,...